血中乙氨基酸细胞计数与肺泡损伤相关,在肺气占主导地位的COPD中
Saya Nakamura1, Keiko Wakahara2, Suguru Majima1
1Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
BMC pulmonary medicine
|October 13, 2024
概括
在不患喘的慢性阻塞性肺病 (COPD) 患者中,高血型乙氨基酸细胞计数与肺损伤相关. 这表明,乙酸性炎症可能会导致肺气泡损伤和COPD的气道变化.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 放射学 放射学是一门学科.
背景情况:
- 血中乙氨基酸细胞数量是慢性阻塞性肺病 (COPD) 管理中的已知生物标志物.
- 在COPD病变发生过程中,乙酸蛋白的确切作用尚不完全理解.
- 这项研究调查了血液中乙氨基水平与COPD肺部结构变化之间的联系.
研究的目的:
- 探索在没有喘的COPD患者中血液中乙氨基基细胞数量和临床参数之间的关系.
- 通过胸部CT.评估血液中乙氨基酸细胞数量和通过胸部CT.确定的特定肺部结构变化之间的相关性.
- 为了评估有关COPD中低衰减区域 (LAA) 的肺组织中乙酸氨基透.
主要方法:
- 在没有喘的93名COPD患者中进行了前性研究.
- 分析了血液中乙酸细胞数量,血清IgE,血清皮质素和胸部CT扫描.
- 乙性COPD定义为血中乙细胞计数≥300/μL;与气道壁厚度和LAA的相关性被检查.
主要成果:
- 19.3%的COPD患者符合乙性COPD的标准 (平均计数为212.1 /μL).
- 血中氨基酸细胞计数与白细胞,基细胞,CRP和唾液中氨基酸细胞相关.
- 在薄呼吸道壁组中,乙酸细胞数量与LAA百分比呈正相关,与扩散能力呈负相关.
结论:
- 没有喘的COPD患者的一个子组表现出血中乙氨基酸细胞数量升高.
- 肺膜损伤和中枢气道壁加厚在COPD可能与eosinophilic炎症相关.
- 这些发现突显出一种潜在的eosinophilic COPD表型,没有并发性喘.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:20COPD: Pathogenesis and Clinical Features
239
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
239
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K